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An overview of nanoparticles commonly used in
fluorescent bioimaging†
Otto S. Wolfbeis
This article gives an overview of the various kinds of nanoparticles (NPs) that are widely used for purposes of
fluorescent imaging, mainly of cells and tissues. Following an introduction and a discussion of merits of fluorescent
NPs compared to molecular fluorophores, labels and probes, the article assesses the kinds and specific features
of nanomaterials often used in bioimaging. These include fluorescently doped silicas and sol–gels, hydrophilic poly-
mers (hydrogels), hydrophobic organic polymers, semiconducting polymer dots, quantum dots, carbon dots, other
carbonaceous nanomaterials, upconversion NPs, noble metal NPs (mainly gold and silver), various other nano-
materials, and dendrimers. Another section covers coatings and methods for surface modification of NPs. Specific
examples on the use of nanoparticles in (a) plain fluorescence imaging of cells, (b) targeted imaging, (c) imaging of
chemical species, and (d) imaging of temperature are given next. A final section covers aspects of multimodal
imaging (such as fluorescence/nmr), imaging combined with drug and gene delivery, or imaging combined with
therapy or diagnosis. The electronic supplementary information (ESI) gives specific examples for materials and
methods used in imaging, sensing, multimodal imaging and theranostics such as imaging combined with drug deli-
very or photodynamic therapy. The article contains 273 references in the main part, and 157 references in the ESI.
1. Introduction
The term imaging can be understood in many ways. Imaging is
a kind of photography in most people’s perception. Scientific
imaging goes far beyond this. Images can additionally be created
by diverse methods such as (near) infrared and Raman spectro-
scopy, nuclear magnetic resonance (often referred to as magnetic
resonance imaging; MRI), radioimaging using respective nuclides,
CT imaging, positron emission tomography, electrochemical
imaging using rastering electrodes, by mechanical methods such
as AFM, and by even more sophisticated scanning methods such
as laser ablation ICP-MS MALDI-MS and the like. It has become
accepted that virtually any method yielding a 2-dimensional
picture (that, ideally, is presented in pseudo-colors) can be referred
to as ‘‘imaging’’. Many of these methods are destructive or require
extensive sample preparation, but others are not and therefore well
applicable to living systems or intact tissues. The use of nano-
particles as contrast agents for in vivo bioimaging using MRI
probably is the largest single field of applications but this topic
is not covered in this review. The purpose of this review is to give
the reader an overview of the wealth of nanomaterials that do exist
for use in fluorescent imaging, and to assist in making decision as
to which material may be selected to solve a specific problem.
Fluorescence (and phosphorescence‡) based imaging has found
particular interest because these spectroscopies are sensitive,
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selective, rich in contrast, and versatile. The past 20 years also
have experienced an enormous increase in resolution that has
arrived at the single nanometer scale. One may first diﬀerentiate
between two kinds of fluorescent imaging. The first involves
imaging based on intrinsically fluorescent (bio)chemical species
(such as NADH in tissues, crude oil in – and on – seawater, or
chlorophyll in all kinds of plants and the open sea). The second
covers methods for imaging of samples or cells that have been
made fluorescent by adding synthetic fluorescent probes, labels,
nanoparticles or nanosensors. The use of such probes is, in fact,
indispensible in order to detect species that are not amenable to
direct fluorometric imaging (such as of pH) but this also implies
the risk of local perturbation by the probe or the material added.
The acquisition of images of biological matter by using
fluorescent probes or fluorescent labels and nanomaterials is
generally referred to as bioimaging and forms a large field of its
own. Letting aside conventional (light) microscopy and MRI,
fluorescence imaging probably is the most widespread method
in biosciences. Respective pictures are attractive, easily compre-
hensive, and can be found in a good fraction of research papers
and magazines. Reviews cover topics such as fluorescent nano-
structures for bioimaging,1 quantum dots for bio-imaging2,3
and single molecule imaging (‘‘one quantum dot at a time’’),4
gold nanoclusters with tunable fluorescence as bioimaging
probes,5 aggregation-induced emission-based fluorescent
nanoparticles,6 nanocomposite particles for bioapplications
including imaging,7 on nanoparticles in drug delivery, thera-
peutics, diagnostics and imaging,8 on quantum dots and polymer
hybrid composites as fluorescent switches and turn-on probes for
sensing anions,9 on aspects of deep tissuemicroscopy and optical
imaging,10 on controlled synthesis, spectra and bioapplications
of lanthanide-doped luminescent nanoprobes,11 on advances in
(NP-based) fingerprint imaging,12 on the intersection of CMOS
microsystems and upconversion NPs for bioimaging and bio-
assays,13 to mention only a few. A review by Bu¨nzli14 on lantha-
nide luminescence for biomedical analyses and imaging contains
a section 5.6. on improving sensitivity by using certain nano-
particles. Others are cited later in the respective sections and
in the ESI.†
The term fluorescence does not imply a single spectroscopic
method but rather includes a variety of techniques in that images
can be acquired by measurement of intensity, decay time (lifetime)
and polarization, but also by studying eﬀects caused by resonance
energy transfer, (dynamic) quenching, or photo-induced electron
transfer. Optical imaging was limited to resolutions of a few
100 nm until about 1995, but substantial thrust in terms of
resolution resulted from the availability of fluorescent methods
of imaging on the nanoscale by methods such as STED, PALM, or
STORM, all based on laser technology. Chemo- and biolumines-
cence can also generate images15 but chemiluminescence requires
the addition of reagents and usually is unidirectional in that an
increase in the concentration of an analyte can only be monitored.
Both methods are time-dependent.
When focusing now on bioimaging based on synthetic
fluorescent probes and nanoparticles, one may diﬀerentiate
between three techniques. (1) In the most simple one, a strong
fluorophore or fluorescent nanoparticles are internalized into
cells so that they can be imaged. The only purpose of such
fluorophores and nanomaterials is to render cells or tissue
fluorescent. They do not possess (and are not expected to
possess) aﬃnity for a specific site, nor do they respond (like
indicator probes) to the presence of chemical species such as
certain ions or organic molecules. (2) The second technique is
referred to as ‘‘targeted bioimaging’’. It enables specific
domains or species to be detected, very much like immuno-
staining or fluorescence in situ hybridization. In order to
accomplish this, fluorophores or nanoparticles are applied
whose surface has been properly functionalized, for example
with receptors, ligands, antibodies or oligomers so as to recog-
nize the specific counterpart. Examples include targeting of
tumor markers, genes, mitochondria, membranes, or the amy-
loidic plaques in Alzheimer-associated tissue. (3) The third
technique is making use of probes and nanomaterials with
sensing capability. This enables (bio)chemical species to be
imaged that are to not intrinsically fluorescent. Examples
include imaging of the distribution of chemical species such
as pH values, glucose, calcium(II) or oxygen in the living and
metabolizing cell, if not in tumor cells or in cells exposed to
candidate drugs. This group also involves nanosensors for
temperature. Representative examples for each of these techniques
will be presented in Section 5.
2. Fluorescent nanomaterials and
nanoparticles versus molecular
fluorophores, labels and probes
The availability of nanomaterials for purposes of imaging has
generated a variety of methods for imaging, with features
including improved brightness (defined as absorbance times
quantum yield), inertness to their microenvironment and a more
even distribution (unless targeted imaging of certain domains is
desired, of course). Nanoparticles (NPs), in contrast to molecular
probes, often are not cytotoxic and do not suﬀer from nonspecific
binding by cellular biomacromolecules or unwanted sequestra-
tion. Binding of molecular probes by cellular proteins (or sites)
can aﬀect both the optical properties of the probe and even the
function of the protein or the binding site. Dyed NPs, or
intrinsically fluorescent NPs, in contrast, are virtually inert and
do hardly interact with cellular proteins nor are their optical
properties aﬀected by the proteins outside. Not surprisingly, all
known NPs have photostabilities that are distinctly better than
those of molecular probes. Many NPs can be easily internalized
into cells and tissues (depending on charge and surface
chemistry; positively charged facilitates internalization) and
can be even targeted to specific sites. Compared to fluorescent
proteins one notes the more simple handling of NPs and more
predictable results. Many kinds of NPs are commercially avail-
able. The simplicity of loading or labeling with fluorophores or
NPs is a particular issue if hundreds of cell lines are being
handled simultaneously, for example in high-throughput
screening. Second-harmonic generation (which results in low
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background noise) is more easily accomplished with NPs as
demonstrated in the review by Dempsey et al.16 on respective
nanocrystals for in vivo imaging, in particular on nano-
diamonds, nonlinear crystals, quantum dots and SERS NPs.
Finally, it is fair to say that nanosensors have calibration plots
that are quite similar if not identical if acquired in vitro and
in vivo. Molecular probes, in contrast, are quite diﬀerent in that
respect. It is a matter of fact that one must never use a
calibration plot that was established in plain buﬀer solution
to quantify a parameter with data acquired in a cellular system.
3. Kinds of nanomaterials often used in
bioimaging, and their specific features
A complete coverage of all the nanomaterials used so far in
bioimaging would by far exceed the frame of this review but
rather fill a book. The following is a discussion of the nano-
materials most often used for purposes of bioimaging. These
include NPs made from silica and organically modified silica,
hydrophobic and hydrophilic organic polymers, semiconducting
organic polymers, quantum dots, carbonaceous nanomaterials
including carbon (quantum) dots, carbon nanoclusters and
nanotubes, nanodiamonds, upconversion materials, metal
particles, metal oxides and others. The discussion on the
potential cytotoxity of NPs is going on, and numerous studies
have been performed to investigate the potentially harmful or
the perturbing eﬀect of NPs on physiological systems.17
3.1. Fluorescently doped silicas and sol–gels
Silica nanoparticles (SiNPs) were among the first ones to be
used in bioimaging. Excessive literature on their uses does
exist.18 The group of Wiesner has reviewed19 the state of the
art in SiNPs for use in sensing/imaging and has described
numerous kinds of SiNPs, among them the one-pot synthesis of
PEGylated mesoporous and fluorescent SiNPs possessing a
single pore, tunable sizes of around 9 nm, and narrow size
distributions.20 In fact, mesoporous silica (in addition to
materials related to ‘‘controlled porous glass’’) are more often
used now because they can be heavily loaded with fluorescent
dyes, photosensitizers or diagnostic reagents as will also be
shown in Section 6. Fluorescent mesoporous silica can be
obtained via hydrothermal reaction and functionalized, if
desired, with reactive siloxanes.21 Such particles possess low
cytotoxicity and excellent cell imaging capability.
SiNPs can be easily doped with various kinds of organic,
metal–organic and metallic fluorophores, and emission wave-
lengths range from 300 to 1000 nm, with a trend towards NPs
possessing longwave (4600 nm) emissions22 because the
fluorescence of NPs at wavelengths of 4500 nm is often
interfered by the autofluorescence of cells. Color, decay times
and size are widely tunable, and dopants can be hydrophobic,
hydrophilic, or ionic. SiNPs also may be coated with fluoro-
phores but attention has to be paid to possible aggregation
effects that usually are accompanied by self-quenching. Two-
photon excitation has been demonstrated but this depends on
the kind of fluorescent label. SiNPs and their aggregates of
4300 nm in size cause strong light scattering. SiNPs are fairly
well biocompatible (i.e., not harmful to cells and tissues). Cell
permeability depends on zeta potential. If negatively charged,
they hardly pass cell membranes. They are virtually nontoxic,
easily excreted (unless particle sizes exceed 50 nm), but also
quickly coated by intracellular proteins and attacked by the
immunosystem. Their surface can be easily modified with a
variety of coatings and using standard silica (and sol–gel)
surface chemistry. Particles do not swell but tend to aggregate
in the presence of bivalent ions unless inert shells are deposited
on the surface. Mesoporous silica structures warrant strongly
increased surface areas and enable high loading of cargo for
cellular imaging and targeting. The state of the art in designing
and characterizing fluorophore-doped SiNPs for bioapplications
has been reviewed.23
SiNPs and other NPs are often doped with luminescence
lanthanides. Their use in bioimaging has been reviewed by
Chen et al.,24 and the fabrication of down-converting and
up-converting luminescent probes for optical imaging by Zhang
et al.25 Lanthanide-based fluorophores have attractive features
such as (a) relatively long decay times which facilitate time-
resolved fluorometry and, thus, eﬃcient background suppression;
(b) fairly narrow emissions; (c) single-photon and two-photon
excitation; and (d) upconversion luminescence and downconver-
sion luminescence. Lanthanide doped SiNPs are obtained by
incorporating lanthanide ions, or by grafting the SiNPs with
complexes such as Eu(III), Tb(III) or Gd(III).26 Such fluorescent
NPs have decay times between 0.35 and 1.87 ms (which facilitates
gated spectroscopy), do not photobleach, and display the typical
narrow emission bands of lanthanide ions. Other examples for
lanthanide doped NPs (also with materials other than silica) will
be given in the following sections and in the tables. In addition to
silica, NPsmade from titania and zirconia and doped with organic
and inorganic fluorophores also are known but less often used.
They are treated in Section 3.11 (on Other Nanomaterials).
Sol–gels and organically modified sol–gels (ormosils) may
also be used for forming NPs. A large variety of materials are
known. Their porosity can be governed by the proper choice of
materials and by varying experimental conditions such as acid
or base catalysis. Sol–gels are prepared by polycondensation
of tetraalkoxysilanes, and ormosils by copolymerization of
mixtures of tetraalkoxysilanes with alkyl-alkoxysilanes in varying
ratios, or from alkyl-alkoxysilanes only. A large variety of materials
is known depending on whether mono-, di- or trialkylsilanes of
general formula (R1)x(R2O)3xSi–R1 (where R1 is alkyl or aryl, and
R2 is alkyl) are being used. The NPs usually are made fluorescent
by non-covalent doping with various kinds of fluorophores.
Unless pore sizes are small, covalent immobilization is advised,
however. Colors, decay times and particle size are widely tunable.
As with SiNPs and others, fluorescence at 4500 nm is often
interfered by autofluorescence of biomatter. Beads and bead
aggregates of 4300 nm in size cause strong light scattering.
Sol–gel NPs are well biocompatible which can be improved by
PEGylation (see Section 4). Cell permeability depends on zeta
potential in that NPs are hardly cell permeable if negatively charged.
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Sol–gel NPs are nontoxic and – if small enough – are easily
excreted. Their surface can be modified ex vivo with a variety of
coatings, and the surface chemistry of silica and sol–gels is well
established. Particles do not swell but tend to aggregate in the
presence of bivalent ions if their zeta potential is negative.
Photobleaching of the dopant dye can be an issue even though
this is often weaker that in the case of dyes that are molecularly
distributed in cells.
3.2. Hydrophilic polymers
Hydrophilic materials for use in NP-based imaging include the
various kinds of hydrogels, but also natural products such as
cellulose. Nanogels are soft and usually water soluble. If NPs are to
be formed, they have to be crosslinked or mixed with another
material in order to form hybrid materials. Hydrogels are well
permeable to ions and hydrophilic organic species such as glucose
or amino acids, but not to large biomolecules usually. Typical
polymers include polyacrylamide (PAA), polyurethanes, poly-
(hydroxyethyl methacrylamide) (pHEMA), certain poly(ethylene
glycols) or specialty polymers such as Pluronict [a commercial
poly(ethylene glycol)-co-poly-ethyleneoxide)] widely used in
NP-assisted drug delivery. The design of fluorescent organic nano-
structures for bioimaging has been reviewed.27 Depending on the
kind of polymer and the degree of crosslinking, such NPs undergo
substantial (and ionic strength-dependent) swelling inwater, but they
donot tend to aggregate. The emissionwavelengths of respectiveNPs
can be adjusted to almost any wavelength between 300 and 1000 nm
via the dopant, usually an organic or metal–organic fluorophore
whose color, fluorescence, decay time and size are widely tunable.
NPs made from organic monomers can be crosslinked to a
various extent, and this determines many of their properties
including swellability and solubility. The fluorescence of
particles at o500 nm often interfered by autofluorescence of
most cells. NPs prepared from hydrogels are biocompatible,
cell permeable (depending, as always, on the zeta potential),
nontoxic, slowly excreted, fairly quickly coated by intracellular
proteins and attacked by the immunosystem. Many of them can
be degraded by intracellular enzymes. Their surface cannot be
easily chemically modified with additional coatings. Function-
alities such as amino groups are better introduced by adding
a functional monomer to the main monomer and then to
initiate radical polymerization. Techniques are known to prepare
organic polymer core–shell NPs. Fluorescent (and other) dopants
tend to leach into the aqueous environment of the particle unless
firmly retained (electrostatically or covalently). Amino-modified
cellulose was applied in a luminescent sensor for high-resolution
imaging of pH in vivo.28 pH values were imaged by detecting
the green fluorescence of the pH probe fluorescein covalently
linked to aminocellulose. A ruthenium phenanthroline
complex was incorporated into poly-acrylonitrile beads to give
a pH-independent red reference signal. The beads were immo-
bilized in a polyurethane hydrogel on a thin transparent support.
Both in vitro and in vivo experiments revealed the versatility of the
method during physiological and chronic cutaneous wound
healing. The method was later extended to simultaneously image
extracellular wound pH and oxygenation in vivo.29 The same pH
beads were used, and poly(styrene-co-acrylonitrile) particles dyed
with Pd(II)-meso-tetraphenyl-tetrabenzo-porphyrin were added to
give a near-infrared signal that depends on local oxygen partial
pressure.
A typical recent example of the use of a PAA hydrogel is
provided by nanoparticles containing free amino groups that were
prepared by copolymerization of acrylamide and methylene-
bisacrylamide with 3-aminopropyl-acrylamide and labeling the
terminal amino groups with pH probes such as fluorescein,
Oregon Green, Alexa 633, and others. The resulting sensor NPs
cover a wide range of pH (4.0–8.0) which is needed in
certain situations even in cellular imaging.30 In addition to the
widely used crosslinked polyacrylamides (PAAs), other acryla-
mides including polymethacrylamide or poly(N-alkylacrylamides)
were employed. For example, core–shell microgels containing
indicators were fabricated31 by two-stage free radical precipitation
polymerization of N-isopropylacrylamide. The shell of the
microgel exhibits a low critical solution temperature and
undergoes a transition from a swollen state to a de-swollen
state, associated with a hydrodynamic radius of B450 nm at
25 1C (in vitro) and ofB190 nm at 37 1C (in vivo). The microgel
readily enters the cytosol which makes it a potential candidate
for the delivery of indicator probes into the cytosol.
The Pluronict hydrogel (see above) was used to fabricate
nanosensors for fluorescent imaging of physiological pH
values.32 Features include (a) very small diameters (12 nm);
(b) biocompatibility due to the use of a hydrogel kind of
material, and (c) the lack of toxicity. The nanosensors were
incorporated into an agar film to enable continuous monitoring
of the pH value of bacterial cultures, and thus of their growth.
Dually responding nanosensor particles were reported that were
prepared from an organic–inorganic composite (Pluronict rein-
forced with silica) and used for simultaneous imaging of oxygen
and pH in the cellular cytosol.33 Fig. 1 shows a schematic of
the preparation of the dual nanosensor for oxygen and pH, the
architecture of the NPs, and the chemical structures of the probes
used. Other multiple (bio)sensors, i.e. sensors capable of two or
more analytes simultaneously have been reviewed,34 but only a
moderate fraction of them makes use of nanomaterials.
Nanogels (like NPs) are of interest in being extremely soft
materials that take up water in fraction between 10 and 90%. The
gels are well permeable to hydrophilic species and can be made
fluorescent by simple labeling with inert labels andmade responsive
by attaching a fluorescent probe. Nanogel particles are well suited to
image pH values inside cells.35 In a method termed CLARITY,
nanoporous hydrogel-hybridized forms of intact mouse brain were
prepared and crosslinked to a three-dimensional network of hydro-
philic polymers.36 They are optically transparent and permeable
macromolecules. Tissue imaging is said to reveal local circuit wiring,
cellular relationships, subcellular structures, protein complexes,
nucleic acids and neurotransmitters. CLARITY also enables intact-
tissue in situ hybridization, immunohistochemistry in non-sectioned
tissue, and antibody labelling. Fluorophore-labeled polymeric nano-
gels for sensing temperature (T) have attracted much interest
because they pave the way to sense T inside cells. The topic has
been extensively reviewed.37
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3.3. Hydrophobic organic polymers
Polystyrene nanoparticles (PS-NPs) are highly hydrophobic and
can be doped with apolar fluorophores with emission peak
wavelengths that range from the near UV to beyond 1000 nm.
Their color, decay times and size also are widely tunable.
Doping with lipophilic materials is preferred because ionic
probes are poorly soluble in hydrophobic NPs from which the
probes tend to leach out. As in all kinds of NPs for use in
imaging, any fluorescence occurring at below 500 nm is inter-
fered by the autofluorescence of biomatter. An (organic) dopant
fluorophore can photobleach if exposed to strong laser light.
PS-NPs are fairly biocompatible (i.e., not harmful to cells and
tissue), fairly well cell permeable, nontoxic, and their excretion
is slow. If placed inside cells, they are only slowly coated by
intracellular proteins and hardly attacked by the immuno-
system. The modification of their surface is limited to certain
functional groups. Functionalities (such as amino groups) are
best introduced by the addition of co-reagents containing such
groups to the monomer before starting emulsion polymeriza-
tion. Post-modification and additional coating are rather diﬃ-
cult. PS-NPs do not measurably swell in water and do not
readily aggregate, but this depends on their charge and zeta
potential. One of the first nanomaterials for sensing purposes
consisted of (pH-insensitive) fluorescent PS beads coated with
polyaniline whose absorbance is pH dependent over a large
range of pH values. Depending on the actual pH value, the
coating screens oﬀ the emission of the beads.38 PS-NPs are well
permeable to gases but impermeable to charged species includ-
ing proteins. Particles with an average diameter of 85 nm were
loaded with an oxygen-quenchable luminescent ruthenium
complex and then used to image oxygen inside cells following
2-photon excitation.39
Polyacrylonitrile (PAN) NPs can be doped with fluorophores
with emission wavelengths ranging from 300 to 1000 nm,
preferably with hydrophilic dyes. Color, decay times and size
widely tunable. Beads and aggregates of4300 nm in size cause
light scattering. PAN is fairly biocompatible (not harmful to
cells and tissue) and fairly well cell permeable, nontoxic, easily
excreted but slowly coated by intracellular proteins. It is hardly
attacked by the immunosystem. Its surface is rather inert and
cannot be readily modified once the particles have been
formed, usually by precipitation by adding water to a solution
of PAN in dimethylformamide. PAN particles do not swell but
there is a tendency to aggregation. Fluorophore-doped PAN-NPs
were applied, for example, to referenced imaging of pH and
temperature with sub-mm spatial resolution.40
Biocompatible fluorescent organic NPs with tunable photo-
luminescence were obtained via one-pot oxidation of poly-
dopamine and subsequently utilized for cell imaging,41 and
water dispersible red fluorescent organic NPs for use in cell
imaging were reported by Luo.42 Quantum-dots conjugated to
dopamine function as redox coupled assemblies and can be
applied to in vitro and intracellular pH sensing.43 Other polymers
include poly(vinyl butyral)44 that was labeled with a perylene dyes
that is easily taken up without coating and does not display
in vitro cytotoxicity on human cancer cells. Hu et al.45 have
introduced a class of organic nanocomposites with function-
alities for both fluorescence imaging and magnetic therapy.
Magnetic NPs (5 nm in diameter) were incorporated into the
amphiphilic block copolymer poly(styrene-b-allyl alcohol) that
was labeled with pyrene. The fluorescence of the resulting NPs
(200 nm i.d.) was exploited when imaging cancer cells, while
magnetically controlled mechanical damage of cell membranes
represents a way for cancer cell treatment referred to as magne-
tolytic therapy. Magnetic field induced heating may pave, in
future, the way to hyperthermal cancer therapy. This is schema-
tically shown in Fig. 2. For numerous other examples, see
Section 6.
3.4. Semiconducting (organic) polymer dots (P-dots)
These come in addition to more conventional (dyed) NPs such as
those made from polystyrene, polyacrylamide etc. The polymer
usually is prepared from aromatic precursors possessing polymer-
izable double or triple bonds. Particles (as needed for imaging)
Fig. 1 Structure of a nanosensor for dual sensing of oxygen and pH. Its
core consists of Pluronic F-127, a nonionic, surfactant triblock copolymer
composed of a central hydrophobic chain of poly(propylene oxide) flanked
by two hydrophilic chains of poly(ethylene glycol) (PEG) and reinforced
with silica. The NPs are capped with PEG. The oxygen probe (PtTBTBP) and
the reference fluorophore TFPP are located in the core, and the pH probe
(FITC) is conjugated to the terminal ends of the PEG capping. Reproduced
from ref. 33 with permission (2014) of the Am. Chem. Soc.
Fig. 2 Left: TEM of fluorescent organic nanobeads containing magnetic
NPs. Right: bimodal use of the nanobeads for purposes of imaging cancer
cells (top) and magnetically induced lysis of cell membranes. From ref. 45
with permission (2014) of the Am. Chem. Soc.
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are prepared by either emulsion polymerization or nano-
precipitation.46 Doping with fluorophores is not needed. The
backbone of conjugated polymers behaves like an array of light-
harvesting units that exhibit a larger optical cross section com-
pared to small organic molecule dyes. Photobleaching was not
reported so far. Fine-tuning of the conjugated polymer structure
and the polymeric encapsulation matrix leads to fluorescent
probes with specific spectral properties and targeting capability.
P-dots display strong fluorescence that often extends far into the
NIR, are highly inert and do not swell in water. Little is known
about biocompatibility, internalization, and excretion from tissues.
Their uses in imaging and therapy have been reviewed.47
Fluorescent nanodots consisting of semiconducting polymer
blends can be attached to peptides (such as chlorotoxin)48 and
then can be used for targeted imaging (of malignant brain
tumors, for example) in clinical diagnosis. By coupling the
pH-indicator fluorescein to P-dots, a material is obtained that
displays two fluorescence peaks, one being pH sensitive, the
other not so that it can acts as an internal reference. Fully
reversible pH sensing was demonstrated49 for the pH 5.0 to
8.0 range. Intracellular pH values were determined by imaging
of HeLa cells following the uptake of the P-dots by endocytosis.
Tetraphenylethene-based fluorescent organic NPs undergo
aggregation-induced emission inside cells and this was moni-
tored via cell imaging.50 The fluorescence of conjugated polymers,
particularly if anionic, can be quenched by ions such as Cu(II).51
Semiconducting P-dots (20 to 50 nm) can also serve as photo-
acoustic probes for real-time imaging of reactive oxygen species in
living mice tissue where they accumulate quite readily.52
3.5. Carbon dots
Carbon dots (C-dots53), first reported in 2006, are said to be
clusters of carbon atoms (for definitions see ref. 54) with dia-
meters of typically 2 to 8 nm, but also contain substantial
fractions of oxygen and hydrogen if not nitrogen. They do not
measurably swell in aqueous solution but aggregation was occa-
sionally observed. C-dots can be made strongly fluorescent and
need not be doped or labeled. Their emission color can be tuned
to some extent by varying the experimental conditions of synth-
esis. Both the excitation and emission spectra are very wide and
usually extend from the UV to the red (650 nm), a fact that
virtually excludes their use in multiplexing. A fine review on the
synthesis and photophysical properties (and uses in bioimaging)
of C-dots is available.55 It includes the very true statement that
‘‘C-dots have a muchmore comprehensive definition compared to
graphene quantum dots.’’ The QYs of C-dots range from 5 to 30%.
Fig. 3 shows the emission spectra of carbon dots at diﬀerent
excitation wavelengths from 330 to 475 nm. Their strongest
fluorescence is blue, but longwave excitation (at 4460 nm)
induces green to yellow emission. A review on the synthesis,
properties and applications of C-dots contains an interesting
section on the origins of their excitation wavelength dependent
emission, and particularly the controversial upconverted lumi-
nescence.56 The emissions also are likely to be pH-dependent.
Single-particle fluorescence intensity fluctuation (‘‘blinking’’) has
been reported recently.57 Decay times are in the nanosecond time
regime and do not vary much. The fluorescence of C-dots can be
of the upconversion and the down-conversion type.
C-dots, and carbon nanoparticles in general, can be single-
photon excited and multi-photon excited. C-dot-based inorganic–
organic nanosystems were applied, for example, to two-photon
imaging of pH variation in living cells and tissues.59 C-dots are
fairly well biocompatible (i.e., not harmful to cells and tissue
within a few days), fairly well cell permeable, not known to be
toxic, easily excreted, weakly interacting with proteins, and hardly
attacked by the immunosystem. Functional surface engineering
for purposes of bioconjugation and imaging is more difficult
than in the case of Q-dots but possible.60 They neither swell nor
photobleach. Their fluorescence is pH dependent and quenched
by iodide61 (and probably by other notorious quenchers too).
A recent review covers the subject.62
In terms of synthesis, both top-down and bottom-up
approaches are known. The resulting C-dots, in fact, always
contain substantial fractions of oxygen (up to 50%) and also
nitrogen if a nitrogen-containing substance such as an amino
acid is added during synthesis. And yet, they are often termed –
mainly by Chinese authors – graphene quantum dots even
though graphene by definition consists of C and H only and is
nonfluorescent. Examples where the application of ‘‘graphenes’’
is claimed but materials other than sp2-graphenes have been
used include, for example, intracellular fluorescence imaging
with a ‘‘graphene’’-based fluorescent probe,63 and the use of
highly biocompatible ‘‘graphene’’ nanosheets for cellular
imaging.64 A particularly confusing example is represented65 by
an article entitled The in vivo and in vitro toxicity of graphene
quantum dots that has nothing to do with graphene (which is free
of oxygen by definition and non-fluorescent). The authors have
prepared the highly fluorescent (!) graphene material by oxidation
(!) and also claim it to possess a particularly high oxygen content (!).
C-dots have been prepared from numerous organic materials
and natural products containing carbon in various form, one
example being58 the preparation of 3 nm blue fluorescent C-dots
from cowmilk by heating it to 180 1C for 2 h. The particles can be
Fig. 3 Wavelength dependence of aqueous solutions of carbon dots in
water at excitation wavelengths between 330 and 475 nm. Reprinted from
ref. 58 with permission (2014) of the Am. Chem. Soc.
Review Article Chem Soc Rev
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
6 
Ja
nu
ar
y 
20
15
. D
ow
nl
oa
de
d 
on
 2
3/
02
/2
01
6 
15
:3
2:
51
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
This journal is©The Royal Society of Chemistry 2015 Chem. Soc. Rev., 2015, 44, 4743--4768 | 4749
used to image U87 cells. If C-dots are doped with nitrogen,66 they
are even more strongly fluorescent. Both hydrophilic and hydro-
phobic C-dots are known. Hydrophilic materials are preferred in
imaging.67 Hydrophobic materials are less often used but also
available by microwave synthesis.68 Raw C-dots are mainly pre-
pared by microwave induced thermal carbonization of molecular
precursors such as glucose (and other carbohydrates), citrate,
(poly)glycols, often in the presence of a nitrogen source (such as
tryptophan or EDTA). Surface passivated (und, therefore, bright)
C-dots can be directly synthesized by microwave induced pyrolysis
of glycerol in the presence of 4,7,10-trioxa-1,13-tridecanediamine.69
C-dots can also be isolated from soot, or prepared from glucose
with P2O5 at room temperature.
70 C-dots may be rendered to
more strongly fluorescent by alkali or acid-assisted ultrasonic
treatment.71
Photoluminescent C-dots have also been produced by laser
ablation of graphite followed by oxidation with nitric acid and
functionalization with diamine-terminated poly(ethylene glycol).72
They show multicolor fluorescence.73 C-dots can be produced
inexpensively and on a large scale. Fluorescence is conferred or
improved by chemical treatment (or passivation) of the surface, for
example by oxidation, doping with inorganics, or capping. Water
dispersible C-dots with tunable photoluminescence can also be
synthesized74 via hydrothermal oxidation of nanodiamonds and
were subsequently utilized for cell imaging. Carbon nanoparticles
(10 nm i.d.) for use in fluorescent bioimaging can be obtained
now75 on the milligram to gram scale by carbohydrate carboniza-
tion (even though in our experience this method is diﬃcult to
reproduce not the least because of an inadequate experimental
part). Table 1 gives examples of CNPs (prepared on the gram scale)
along with colors of emission (from blue to red). Red-fluorescent
CNPs are preferred because autofluorescence of biomatter is
weaker in this spectral range (Fig. 4).
Both C-dots with invariable and with continuously tunable
emission are known.76 They enable ratiometric sensing of pH
values via the ratio of the intensities of the excitation-
independent and pH-independent blue emission and the
excitation-dependent and pH dependent full-color emissions.
Ratiometric (blue and green) fluorescent nanosensors have been
described77 that are based on water soluble carbon nanodots
withmultiple sensing capacities. This, however, is an euphemism
for poor selectivity in that the dots respond to temperature, pH,
and to Fe(III) ions, all of which mutually interfere.
3.6. Other carbonaceous materials
Other nanosized carbon allotropes include fullerenes (C70
mainly; these being much smaller than C-dots), and the larger
species including carbon nanotubes (CNTs; single walled and
multiwalled), nanodiamonds, graphene (which is nonfluorescent),
and the oxidized species graphene oxide, reduced graphene oxide,
graphite oxide, graphene quantum dots (often synonymously used
for C-dots; see Section 3.5.) and the like. Other authors refer to
their materials as graphene (or graphene dots) even if the material
was prepared by reduction of graphite oxide (by Hummers
method) and still contains large fractions of oxygen. It may be
better termed ‘‘reduced graphite oxide’’. There is much confusion.
The fluorescence of graphite oxide78 (like that of C-dots79) is
sensitive to pH. Like C-dots, such carbon nanomaterials need
not be doped with fluorophores and are extremely photostable.
The colors of emission of all known variants depend on the
wavelength of excitation. Excitation in the UV (350–380 nm)
often results in good brightness and blue fluorescence, but
excitation wavelengths can be as long as 650 nm and fluores-
cence then occurs in the near IR as is shown below. The decay
times of fluorescence are in the order of nanoseconds. Nano-
sized fluorescent graphite oxides (nano-GOs) with different size
distribution were prepared via a one-pot hydrothermal route
using ultra-small graphite powder as a starting material and
subsequently separated using dialysis tubes with different
molecular weight cutoff.80 Such nano-GOs were found to be
readily internalized by A549 cells and then located in the
cytoplasm. They display size-dependent photoluminescence
(green, yellow, red) and excellent biocompatibility.
Graphene81 and (color-tunable) fullerenes82 have not often
been used for purposes of imaging because of their lack of
(or rather weak) fluorescence. Fullerene C70 (unlike C60 which is
nonfluorescent) displays normal and delayed fluorescence
which is strongly quenched by oxygen83 and highly dependent
on temperature.84 Gong et al.85 have isolated red, green and
blue fluorescent hollow carbon NPs from chromatographic
fractions and demonstrated them to be excellent (multi-color)
probes for cellular imaging.
Stabilized graphene oxides were applied to cellular imaging,63
some after having been made highly biocompatible86 or stabilized
and biofunctionalized.87 Blue and green fluorescent carbon NPs
derived with vitamin B1 are also described to be very bright and
applicable to cell imaging.88 Luo et al. have reviewed applications
of carbon-based quantum dots for fluorescence imaging of cells
and tissues.89 Fluorescent graphene quantum dots (GQDs) have
been synthesized90 that display both upconverted and excitation-
independent downconverted photoluminescence. Doping of
GQDs with almost any kind of heteroatom including nitrogen,91
boron,92 sulfur,93 fluorine94 and chlorine95 enhances their
brightness. By coupling them to photocatalytically active rutile
Table 1 Properties of fluorescent carbon nanoparticles (FCNPs) with blue, green, yellow and red emission; containing between 10 and 33% oxygen and
1 to 8% of nitrogen. From ref. 75
FCNP
Molecular mass
or particle size
Composition
(C :H :N :O; in %)
Emission peak and
(excitation) wavelength
Molar absorbance
at excitation wavelength
Quantum
yield (%)
FCNPblue 400–2200 Da 65 : 6 : 8 : 21 440 nm (370 nm) B2  103 6–30
FCNPgreen 2500–14 000 Da, 2–4 nm 75 : 10 : 5 : 10 500 nm (400 nm) B5  104 14
FCNPyellow 1–4 nm 50 : 15 : 2 : 33 560 nm (425 nm) B4  103 12
FCNPred B4–10 nm 70 : 5 : 1 : 24 600 nm (385 nm) B7  105 7
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(TiO2/GQD) and anatase (TiO2/GQD) systems, the complete
visible spectrum of sunlight can be harnessed. Strong two-
photon-induced fluorescence was reported96 for photostable,
biocompatible nitrogen-doped graphene quantum dots
(N-GQDs; possibly C-dots?) for cellular and deep-tissue ima-
ging. Their two-photon absorption cross-section reaches 48 000
Go¨ppert-Mayer (GM) units, which far surpasses that of many
organic dyes. It is comparable to that of the high performance
semiconductor Q-dots and represents the highest value ever
reported for carbon-based nanomaterials. The penetration
depth in phantom tissue revealed an imaging depth as deep
as 1.8 mm. Zhu et al.97 have presented a study on surface
chemistry based routes to modulate the photoluminescence of
GQDs, how to govern the fluorescence mechanism to induce
up-conversion fluorescence, and on bioimaging applications.
Single-walled and multi-walled CNTs are fluorescent in
the NIR but have low quantum yield.98 The one-dimensional
electronic structure of nanotubes results in sharp interband
transitions in the absorption spectra of SWNTs, and in photo-
luminescence in the NIR region (800–1600 nm). These wavelengths
include the tissue-transparent region of the electromagnetic spec-
trum. Their other properties are comparable to those of C-dots.
Fig. 4 Images of gram scale solid samples of fluorescent carbon nanoparticles (FCNPs), of their solutions under appropriate excitations, and their absorption
(—), excitation (  ) and emission (color lines) spectra. Emission spectra have been measured by exciting at 370 nm for FCNPblue, by exciting at 400 nm for
FCNPgreen, by exciting at 425 nm for FCNPyellow and by exciting at 385 nm for FCNPred. From ref. 75 with permission (2014) by Nature Publ. Group.
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Like C-dots, they do not photobleach. While traceable in living
cells, their cytotoxicity is still not refuted,99,100 but carbon nano-
tubes encapsulated by a DNA oligonucleotide remain functional in
live cells for up to three months.101 CNTs have been applied to
Raman imaging, near-infrared (NIR) fluorescence imaging and
photoacoustic imaging but still are less often used than some
other fluorescent nanomaterials. The group of Strano102 has
reviewed advances in molecular recognition based on single-
walled CNTs and respective nanoengineered platforms. These were
used to fluorescently sense species such as ATP, NO, H2O2, and
glucose in cells.
Three-dimensional tracking of single-walled CNTs with an
orbital tracking microscope was demonstrated.103 The technique
was applied to determine the viscosity regimes within live HeLa
cells, and this was used to spatially map corral volumes (0.27–
1.32 mm3), to determine active transport velocity (455 nm s1),
and to calculate local viscosities (54–179 cP) within the cell.
The NIR emission of CNTs (with their second window at 950–
1400 nm) is attractive for in vivo fluorescence imaging due to its
deep penetration depth in tissues and low tissue autofluores-
cence. Genetically engineered multifunctional M13 phages were
shown to assemble single-walled CNTs and ligands for targeted
fluorescence imaging of tumors.104
Nanodiamonds (NDs) are being produced, as powders, by
detonation synthesis on a commercial scale. They have low or
no cytotoxicity.105,106 NDs doped with nitrogen are particularly
bright. Synthetic NDs form fluorescent centers by thermal
annealing and then have rather longwave peaks of excitation
(B560 nm) and emission (B700 nm). The intrinsic red fluores-
cence is strong enough to detect a single 35 nm ND in a cell.107
Others types of NDs possess green fluorescence (peaking at
531 nm) and represent a promising alternative to semiconduc-
tor quantum dots (see above) because they are photostable,
hardly toxic, easily excreted, and can be fairly easily bioconju-
gated. Hydrophobic derivatives of NDs possessing blue emis-
sion have been obtained by modifying the surface with long-
chain alkyl groups.108 NDs do not swell, and their size can be
hardly tuned by chemical means.
3.7. Metal chalcogenide quantum dots (classical Q-dots)
These are typically made from combinations of zinc(II),
cadmium(II), selenide and sulfide. Numerous additional compo-
nents and dopants are known, and sophisticated methods have
been developed to modify surfaces and to create additional
shells. Q-dots have experienced an unprecedented success in
imaging because of their unique properties. They need not be
doped with fluorophores because their fluorescence results from
a photonic quantum eﬀect. The color of emission and their size
are well tunable and interdependent. Decay times (in the low ns
time domain), in contrast, do not vary much. Q-dots display
Gaussian emission spectra (with FWHMs of typically 30 nm)
and therefore have multiplexing capacity (like upconverting
NPs but unlike C-dots). All Q-dots require photoexcitation at
o500 nm where biomatter often strongly absorbs (this causing
an inner filter eﬀect), and fluorescence intensity strongly varies
over time (‘‘blinks’’; however, non-blinking Q-dots have been
described recently). The quantum yield (QY) of Cd/Zn based
Q-dots is rather high (0.3–1.0) which is distinctly better than
the QYs of upconversion NPs (see Section 3.8), for example. Dots
and aggregates of4300 nm in size cause strong light scattering.
Single photon, 2-photon, and recently,109 3-photon excitation and
imaging have been demonstrated, and cross sections can be as
large as 60 000 GM units.
Q-dots are cell toxic unless coated with inert shells, but
passivation and reduced toxicity of CdS dots also were accom-
plished by coating them with DNA.110 They are fairly well cell
permeable but clearance from tissue is diﬃcult, partially
because of their interaction with thiol groups of cysteines in
proteins.111 Their surface chemistry is well established, and
several kinds of surface-modified Q-dots are commercially
available. They do not swell or photobleach but fluorescence
depends on temperature. They are uniquely suited for high
resolution and multiplexed imaging of cells. Good reviews
cover aspects such as on applications to fluorescence spectro-
scopy and imaging,112 rendering them biocompatible,113 on the
cytotoxicity of cadmium-based Q-dots,114 or on nucleic acid-
passivated Q-dots acting as biomolecular templates of varying
form and function.115 Recent work includes the application of
Q-dot nanosensors to fluorescence lifetime imaging micro-
scopy of intracellular pH,116 or of Q-dots loaded with fluores-
cent liposomes in order to perform fluorescence resonance
energy transfer studies and NIR in vivo imaging of mouse
tissues.117 The fluorescence decay time of Q-dots becomes
pH-dependent on coating them with NIR fluorescent dyes.118
The fluorescence of certain Q-dots is quenched by Zn(II) and
Cd(II) ions,119 and this paves the way for imaging such ions
intracellularly. Q-dots may additionally be doped with other
metal ions to give, for example, brightly fluorescent Mn-doped
ZnS, Mn-doped ZnSe, or Cu-doped InZnS particles (10–80 nm in
diameter) which represent a new class of fluorescent nano-
particles with low toxicity.120
Aside from Q-dots composed of Zn(II), Cd(II), sulfide and
selenide there are numerous other kinds of such particles. It is
diﬃcult to keep track with the variety of materials that have been
presented in recent years. NPs with quantum eﬀects can also
consist of group III–V elements. Some are brightly fluorescent,
one example being InP Q-dots functionalized with a Ln(III) chelate
and coated with a cell-penetrating peptide for use as bimodal
imaging agents (MRI and confocal microscopy).121 The reader
is referred to some of the many reviews that exist on the use of
Q-dots in bioimaging. Also see Tables S1–S5 in the ESI.†
3.8. Upconversion nanoparticles (UCNPs)
Most UCNPs (also referred to as upconversion nanocrystals)
consist of hexagonal NaYF4 nanocrystals doped with trivalent
lanthanide ions such as Er(III), Yb(III) or Tm(III). The dopant is
the emitter and additional doping with fluorophores is not
needed. UCNPs display several emission colors (with at least
two strong bands in the visible) whose peak wavelengths
depend on the kind of lanthanide dopant. However, single
color emitting UCNPs of the NaYbF4 type and emitting in the
green,122 red123 and NIR,124 or consisting of lanthanide-doped
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KMnF3 nanocrystals have also been reported.125 The size of
UCNPs is widely tunable (typical sizes ranging from 10 to
100 nm) and aﬀects quantum yields. The control of size and of
the emission and excitation spectra is still a challenge.126 The fact
that most UCNPs display multi-photon (bicolor) emissions also
paves the way to increased resolution in microscopy.127 Their dual
(or multiple) emissions often enable referenced (2-wavelength)
sensing and imaging but unfortunately the ratio of the two
emissions (often green and red) varies with the coating and
undergoes a change if hydrophobic particles of the oleate type
are converted into hydrophilic particles (as preferably used in
bioimaging). The use of upconversion NPs in bioimaging, therapy,
drug delivery and bioassays has been reviewed.128 Very recently it
was shown129 that coating UCNPs with a layer of silver causes
metal-enhanced (plasmon) upconversion and a 30-fold increase in
brightness compared to NPs without the silver core. The NPs used
for imaging of HeLa cells have a 3-layer core–shell–shell architec-
ture of the type Ag@SiO2@Lu2O3:Gd,Yb,Er. The silver induced
plasmon enhancement mechanism in NaYF4:Yb,Er NPs (Maxwell
versus Fo¨rster) was studied in some detail.130
Unlike in the case of carbon dots, the color of the emission
of UCNPs is independent of the excitation wavelength which is
rather longwave (750–1000 nm). UCNPs with oleate capping
(as obtained by the most popular method of synthesis) possess
moderate brightness only, but those modified with hydrophilic
coatings are much less bright, with QYs that hardly exceed 0.5%
in water solution. QYs of 1–3% have also been reported but only
for bulk materials or for dried and aggregated particles. The
seemingly poor QYs of UCNPs are still acceptable because their
anti-Stokes emission allows fluorescence images to be acquired
against a black background.
Remarkably, and unlike in the case of Q-dots, the QYs of UCNPs
also depend on the power density (Watt cm2) of the (cw) laser and
on particle size, with smaller particles of the same kind displaying
smaller QYs.131 It is reminded that the QY of UCNPs is poorly
defined.132 If data are given, it shall also be stated whether these
refer to a single emission band or the total emission (in either
Stokes and anti-Stokes mode). In addition, the size of the particles
investigated must be given along with power density, and how the
inner filter eﬀect of water solutions (under 980 nm excitation) has
been taken into account. UCNPs, if coated with a shell of undoped
NaYF4 (and even silica), are much brighter in water than uncoated
UCNPs. The group of Resch-Genger133 has determined, in a solid
study, the QY of oleic acid-coated UCNPs of type NaYF4:Yb,Er to be
0.35% under well defined experimental conditions. Gargas et al.134
report on seemingly highly attractive nanocrystals (5–8 nm i.d.)
for single-molecule imaging. The brightness under single-particle
imaging conditions is said to be much higher than that of other
compositions. However, the power density applied in the experi-
ments is as high as4106 W cm2 which is hardly tolerated by any
living organism. If such a power density is applied to watery
samples, strong local heating will occur. In fact, if excited with
conventional power density, the luminescence of these UCNPs is so
weak that no spectra can be acquired.
UCNPs may also be applied to optically encode and to
multiplexed imaging of cells and microspheres.135 The method
may be extended to lifetime-based encoding by exploiting their
tunable luminescence lifetimes which are in the microsecond
time regime in case of NaYF4:Yb,Tm.
136 By exciting a single
color band, one can generate more than ten excited state
populations with lifetimes ranging from 25.6 ms to 662 ms
and decode their well-separated lifetime identities which are
independent of both color and intensity.
Host crystals other than NaYF4 have been studied recently.
Light management in UCNPs was demonstrated for ultrasmall
NaGdF4 nanoparticles core–shell architectures to tune their emis-
sion color.137 In another example,138 the brightness of core–shell
nanocrystals (NaLuF4:Gd,Yb,Er coated with a shell of NaLuF4:Yb)
was found to be remarkably higher than that of inert-shell coated
nanocrystals. These particles can be used to image HeLa cells.
Even more complex UCNPs of the type NaLuF4:Gd,Yb,Er were
synthesized recently and applied to bioimaging.139
UCNPs are perfectly suited for bioimaging because fluores-
cence is not at all interfered by the autofluorescence of cells.140
Moreover, they are fairly biocompatible and – if small enough –
cell permeable.141 They are not known to be toxic and easily
excreted. They usually are weakly interacting with proteins but
can be well conjugated to them.142,143 UCNPs are hardly attacked
by the immunosystem, and their surface can be easily modified.
They do not swell but tend to aggregate in the presence of
bivalent ions. Photobleaching cannot occur. Their luminescence
is highly dependent on temperature144 and (rather unselectively)
quenched by several heavy metal ions.145 It is reminded that
photoexcitation of UCNPs with lasers of wavelengths above
800 nm can lead to local heating which can represent a sub-
stantial source of error in quantitative fluorometry.
If excited with NIR lasers, UCNPs heat up. This can be
desired or not. It is not desired in the case of bioimaging,
and an excitation wavelength of 915 nm was recommended to
reduce laser induced heating of UCNPs of the type NaYbF4:
Tm,Er,Ho for deeper in vivo imaging.146 Heating may, however,
also be desired because local heating can be exploited in cancer
therapy. In a typical application, oleate-capped UCNPs were
coated first with a shell of plain silica (also in order to make
them more stable in water solution) and then with a layer of
silica doped with a blue carbocyanine dye. The optical emission
of the upconverting NP was absorbed by the dye to cause a local
heating by up to 21 1C and this causes cells to disrupt. Fig. 5
shows a schematic of the preparation of such UCNPs and
respective TEMs. Even shorter excitation wavelengths can be
used as shown147 with core–shell UCNPs doped with Nd(III) ions
as sensitizers. The upconversion effect already occurs at excita-
tion wavelengths of around 800–820 nm, and this can strongly
reduce sample heating and overtone IR absorption by water.
Others have shifted the excitation wavelength for upconversion
to 1490 nm by using LiYF4:Er nanocrystals.
148
Most syntheses yield water-insoluble NPs which first have to be
surface-modified so as to enable phase transfer to aqueous solu-
tions. Reviews are available on the design, nanochemistry and
applications of UCNPs in theranostics,149 on the surface chemistry
of UCNPs, and how to make them hydrophilic.150 Any surface
modification has, however, an eﬀect on their luminescence and
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colloidal properties.151 The upconversion fluorescence of NPs of
the type Ag@SiO2@Y2O3:Er can be fine-tuned by the size of the
silver core.152 The emission color of lanthanide doped NaYF4
UCNPs also changes during the transformation of crystalline
phases from a, a transition state of a mixed with b, and finally
to the b phase (from red to yellow and finally to green). Coated
with polyethyleneneimine, such particles were used to image
cells.153
Examples for applications include the kinetic determination
of the activity of the enzyme phospholipase.154 A mixture of a
PEGylated phospholipid and a rhodamine-labeled phospholipid
was deposited on an UCNP composed of hexagonal NaYF4 doped
with 20% Yb(III) and 2% Er(III). The 540 nm emission of the UCNP
is used to photoexcite rhodamine B close to the NP. If, however,
the phosphodiester is hydrolyzed by the enzyme phospholipase
inside a cell, the rhodamine is released from the surface of the
UCNP, and this leads to the suppression of the fluorescence of
the rhodamine. The red emission peaking at 655 nm is not
aﬀected by this process and can serve as an internal standard.
Earlier work in the use of UCNPs in chemical sensing and
biosensing has been reviewed.155 A recent review covers their
application to bioassays and bioimaging.156
3.9. Noble metal nanoparticles
Specific features of such NPs include excellent photostability,
water-solubility, size-dependent colors, the lack of swelling, sharp
contrast, the ease of characterization by means such as TEM or
SEM, and an established surface chemistry (often thiol-based)
which is useful if targeted imaging or biosensing/imaging is
desired. The uptake of engineered gold nanoparticles by mam-
malian cells has been reviewed by Dykman and Khlebtsov.157
Gold and silver NPs can also be coupled to plasmonic detection
quite readily or used to generate fluorescence patterns through
diﬀerential release of fluorescent polymers.158
Single gold or silver NPs display rather weak fluorescence
but were used to image HeLa cells.159 While one-photon
luminescence is weak, two-photon luminescence of gold NPs is
strong under excitation at 514 and 633 nm.160 Two-photon
luminescence imaging of cancer cells down to 75 mm depth and
using molecularly targeted gold nanorods161 and of silver NPs162
has been reported. On the other hand, gold NPs can quench
fluorescence by phase induced radiative rate suppression.163 It
was relatively late when it was discovered that metal clusters made
from metallic gold, silver, copper, for example, display strong
intrinsic fluorescence.164 Noble metals are preferred for their
inertness. The surface of these clusters (gold and silver in
particular) can be protected with alkanethiolate monolayers. If
properly modified, they enable plain imaging and targeted
imaging. While luminescence is often attributed to particle size
eﬀects that cause size-dependent fluorescence,165 structural para-
meters such as surface ligands, valence states of metal atoms and
crystallinity of NPs also aﬀect spectra and decay times. Gold NPs
and clusters can be composed of a few to millions of atoms.166
Such ‘‘quantum’’ clusters may also be protected or made targe-
table by coating them with respective proteins.167 For example,
gold NPs were functionalized with luminescent ruthenium(II)
polypyridyl to endow DNA binding capability and applicability
to cellular imaging.168 These structures bind to DNA and undergo
rapid cellular uptake, being localized within the cell cytoplasm
and the nucleus within 4 h. Various kinds of fluorescent silver
nanoclusters (with green, red and yellow luminescences) have
been reported by Dı´ez et al.169 In a smart sensing approach
towards probing phosphate ions,170 gold nanoclusters (NCs) were
capped with 11-mercaptoundecanoic acid and loaded with
Eu(III) ions. The red fluorescence of the gold NCs is quenched
by the Eu(III) ions, but fluorescence is restored upon addition of
phosphate.
3.10. Dendrimers, lipid drops and micelles
Dendrimers (dendrites) are a kind of NPs but much smaller than
those treated so far. They can be both hydrophilic and hydro-
phobic and are easily internalized by cells. Their fluorescence
Fig. 5 (A) Preparation of UCNPs for use in imaging and hyperthermal cancer treatment. (A) Coating of the green UCNPs first with silica and then with
silica doped with the blue and NIR emitting dye Cite-777. (B–D) TEM images of the UNNPs, UCNP@SiO2 core–shell particles, and UCNP@SiO2 particles
coated with the dye–silica nanocomposite. From ref. 146 with permission.
Chem Soc Rev Review Article
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
6 
Ja
nu
ar
y 
20
15
. D
ow
nl
oa
de
d 
on
 2
3/
02
/2
01
6 
15
:3
2:
51
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
4754 | Chem. Soc. Rev., 2015, 44, 4743--4768 This journal is©The Royal Society of Chemistry 2015
usually originates from a label that has to be attached to the
hyperbranched dendrimer skeleton such that no self-quenching
does occur. The brightness of dendrimeric NPs can be controlled
by size, and color by the terminal fluorophore. Their size exceeds
2 nm in very few cases. Dendrimer chemistry is well established.
They have been applied to plain imaging, to targeted imaging,
and to sensing/imaging. Features of fluorescent dendrimers
include very large molar absorbances that can be in the order
of 7 000000 M1 cm1. The quantum yields of conventional
fluorescence range from 0.3 to 0.5 provided that the fluorophores
are arranged such that they do not undergo self-quenching.
Nanoscopic fluorescent dendrimers were designed171 that
carry up to 96 two-photon chromophores and show very large
two-photon absorption cross-sections (up to 56 000 GM units).
Such organic nanodots are said to represent ‘‘brilliant’’ alter-
natives to semiconductor quantum dots. A schematic of such a
dendrimer particle is shown in Fig. 6. In a typical example of its
use in imaging, a dendrimer-based fluorescent pH probe was
used to visualize pH values in living HeLa cells.172 In another
example,173 an amino-terminated generation-5 dendrimer
labeled with a fluorescent marker was integrated into a nanogel
and used to track it inside cells by fluorescence microscopy.
Vinogradov’s group174 has used smart dendrimers labeled
with quenchable probes for oxygen. These are most viable (and
commercially available) nanoprobes for imaging of oxygen in
blood vessels and (cerebral) tissues. A dendrimer termed Oxyphor
G2 [which is a two-layer glutamate dendrimer containing the
Pd(II) complex of tetra-(4-carboxyphenyl) benzoporphyrin] is now
widely used for phosphorescence based assay and imaging of
oxygen. Its chemical structure is shown in Fig. 7. Other (and
much larger) Oxyphors are known, some being more lipophilic,
others more hydrophilic and even being charged.
In addition to dye-labeled dendrimers, there are reports175 on
autofluorescent hyperbranched poly(amido amine) NPs and their
application to cell imaging. They display blue emission, are said
to be nontoxic, and can be recognized by sialo-glycoprotein
receptors on the surface of cancer cells. Similarly, a hyper-
branched conjugated polyelectrolyte was reported for use in
bioimaging.176 It has a core–shell structure, an emission maxi-
mum at 565 nm, a quantum yield of 12% and a Stokes shift of
143 nm in water. Its poly(ethylene glycol) shell minimizes non-
specific interaction. Conjugated to the anti-HER2 affibody, it was
utilized for targeted cellular imaging of HER2-overexpressed
cancer cells. A Q-dot-based ratiometric pH nanosensor with a
dendrimer coating was constructed for measurement of physio-
logical pH ranges. It is based on CdSe/CdZnS nanocrystals where
the pH probe SNARF was conjugated to the poly(amido amine)
dendrimer coating.177 Dendrimer probes for enhanced photo-
stability and localization in fluorescence imaging have been
reviewed.178 The group of Tian179 described multifunctional
nanomicelles for recognition and precisely targeted NIR-light
induced cancer therapy. The nanomicelle encapsulates a
pH-activatable fluorescent probe and a robust NIR photosensi-
tizer and is functionalized with an aptamer for targeting viable
cancer cells. The fluorescent probe can fluorescently detect the
lysosomes for real-time imaging. NIR irradiation causes the
generation of reactive oxygen species to trigger lysosomal cell
death. The Lovell group reported180 on the development of
porphysomes (i.e., nanovesicles formed from self-assembled
porphyrin bilayers) with very large extinction coefficients,
structure-dependent fluorescence self-quenching, and photo-
thermal properties. Their NIR fluorescence, regenerated on
dissociation, results in low-background fluorescence imaging.
Porphysomes are biodegradable and induce minimal acute
toxicity in mice. Similar to liposomes, the aqueous core of
porphysomes can be loaded with drugs or agents. Injected
porphysomes accumulate in tumors of xenograft-bearing mice,
and laser irradiation induces photothermal tumor ablation.
3.11. Other nanomaterials
Numerous other materials have been described for use as fluores-
cent NPs, most with the potential of acting as probes for
(bio)imaging. These include metal oxides, sulfides, tellurides,
Fig. 6 Structure of a hyperbranched dendrimer with terminal fluoro-
phores for use in single-photon and two-photon fluoroimaging. From
ref. 171. r Royal Soc. Chem.
Fig. 7 Chemical structure of the dendrimeric nanoparticles used (under
the tradename Oxyphore G) for imaging of oxygen. It consists of a
Pd(II)benzoporphyrin core and a glutamate-based periphery whose carboxy
groups are dissociated which imparts water solubility. From ref. 174 with
permission (2014) by Springer Verlag (Berlin).
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fluorides, complex ionic species (including more than one
cation and anion). They cannot be discussed here in depth
but a selection is given. They usually are covered with addi-
tional layers (such as reactive groups and/or PEG) or coated
with shells of (inert) solid materials, often silica. The list of
conceivable candidates for preparing NPs of various size and
optical properties is virtually endless. One typical example is
given by Nd(III)-doped LaF3 nanoparticles that can be applied to
imaging in the second optical window of biomatter.181 Fluori-
dated hydroxyapatites (HAps) were doped with Eu(III) or Tb(III)
that were shown to be viable NPs for cell imaging.182 They were
made water-dispersible by hydrophobic/hydrophilic trans-
formation with the surfactant Pluronict F127. Similar NPs
were obtained by PEGylation of fluoridated HAp nanorods
doped with Ln(III) and used for cell imaging.183 A comparative
study was performed on the structure of Tb(III) doped fluores-
cent HAp nanocrystals184 and showed them to possess good
cytocompatibility and cell imaging capability.
NPs consisting of a YVO4 matrix and doped with trivalent
lanthanides and phosphorus enable multicolor tuning at a single
wavelength of excitation.185 Emission wavelengths and intensity
ratios can be controlled using the host–activator system and
the concentrations of dopants. By coupling luminescent Tb(III)
complexes to magnetite (Fe3O4), NPs are obtained
186 that display
paramagnetism, low cytotoxicity, and high cell uptake. If coated
with folic acid, they can be used for in vitro fluorescence and
magnetic resonance targeted imaging of cells that overexpress
the folate receptor, for example the HeLa cells.
Titanium dioxide (‘‘titania’’) is easily prepared and doped,
for example with europium(III), and respective TiO2 hollow
nanoshells are viable two-photon nanoprobes. If coated with
poly(ethylene imine), they adhere to HeLa cervical cancer cells.187
Mesoporous titania was deposited on silver–silica core–shell NPs
to result in a nanoarchitecture of type Ag@SiO2@mTiO2. The
metal core acts as an enhancer of fluorescence. The particles were
loaded with the fluorescent flavin mononucleotide and the
fluorescent cancer drug doxorubicin and used for simultaneous
bimodal (fluorescence and SERS) imaging of drug delivery.188
Amino-functionalized zirconia NPs (5 nm i.d.) doped with Ln(III)
ions were prepared and used for time-resolved fluorescence
resonance energy transfer detection of avidin with a detection
limit of 3.0 nM. The ZrO2 NPs can specifically recognize cancer
cells overexpressed with a urokinase plasminogen activator
receptor.189
Fluorescent Ag2S nanoclusters possess tunable photolumi-
nescence that extends from the red to the NIR. They can be
made biocompatible and applied to bioimaging by introducing
glutathione as the capping reagent.190 Two-photon excitable
CaF2 NPs doped with Tm(III) and Yb(III) represent multifunc-
tional nanoprobes for deep-tissue fluorescence bioimaging.191
On the basis of the strong Tm(III) ion emission (at around
800 nm), tissue penetration depths as large as 2 mm have been
demonstrated, which is more than 4 times that of the visible
emissions in comparable lanthanide-doped CaF2 NPs. These NPs
with an outstanding penetration depth, together with the fluores-
cence thermal sensitivity are well suited as multifunctional
nanoprobes for high-contrast and deep-penetrating in vivo
imaging. Other sulfides also display quantum dot-like emis-
sion, for example 5 nm NPs prepared from lead(II) sulfide which
were protected with oleic acid and oleyl amine and made
hydrophilic by hydroxylation at the terminal end of the alkyl
chains.192
Nanoscale metal–organic frameworks (often handicapped by
hydrolytic decomposition) were shown to enable bioimaging193 by
incorporation of luminescent or high Z element building blocks.
They can serve as viable contrast agents. The pores and channels
of such frameworks may also be loaded with active agents and
drugs. Colloidal and stable silicon (not silica!) NPs with their red
fluorescence and being grafted with hyperbranched polyglycerol
are water soluble and display good colloidal stability.194 The
transformation of the hydrophobic surface of plain silicon NPs
into a hydrophilic surface makes them water-soluble and suitable
for specific targeting overexpressed cervical cancer cells and
glioblastoma cells. Such particles are said to be ‘‘bright’’ but it
is difficult to assess brightness (defined as molar absorbance
multiplied with quantum yield) if neither of the two is known.
Inorganic semiconductor fluorescent NPs consisting of ultrathin
silica carbide (SiC) also display pH-dependent luminescence and
can be used195 to probe intracellular pH values in the range from
5.6 to 7.4.
Lipid NPs – like hydrogels NPs – are soft but highly apolar.
They resemble hydrophobic dendrimers and can be easily
prepared but often lack stability if placed in complex systems.
Gravier et al.196 have described lipid NPs loaded with fluoro-
phores (NIR dyes including Indocyanine Green) for use in
fluorescence imaging (so called ‘‘lipidots’’). Multichannel
in vivo imaging of lymph nodes in mice was demonstrated for
doses as low as 2 pmol of NPs which have very high ‘‘molar’’
absorbance. Their cytotoxicity is very low. An interesting example
of a micelle-based NP probe was reported by Zhou et al.197 who
have prepared such NPs from micelle-forming block copolymers
with tertiary amine and poly(ethylene oxide) segments. If the
local pH value is below the pKa of the ammonium groups, the
micelles dissociate into unimers which is accompanied by a
strong increase in fluorescence due to the suppression of
homo-FRET. These NPs are highly sensitive to pH and were
applied to target specific endocytic organelles in living cells and
to image pH values. The method of pH-induced micellization
was extended to a panel of multicolored nanoparticles with
a wide emission range (500–820 nm) and different pH
transitions.198 Wang et al.199 have shown that ultra-small
fluorescent nanosensors for oxygen can be obtained by a rather
simple method. The materials have a hydrophobic core capable
of firmly hosting hydrophobic luminescent oxygen probes and
a shell composed of a long-chain poly(ethylene glycol) which
renders them cell-membrane impermeable but yet highly
sensitive to oxygen. These NPs are highly stable in aqueous
solutions, in cell culture media, and in extracellular fluids such
as blood, interstitial and brain fluid. Four kinds of nanosensors
were presented, whose excitation spectra cover a wide spectral
range (395–630 nm), thus matching many common laser lines,
and with emission maxima ranging from 565 to 800 nm,
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thereby minimizing interference from background lumines-
cence of biomatter.
4. Coatings and surface modifications
Coatings and surface modifications of NPs can serve two pur-
poses. The first is to render NPs fluorescent, the second is to
improve the properties of the NPs, for example by making them
brighter, better biocompatible, or cell-permeable. NPs can be
made fluorescent by attaching fluorophores to their surface by
depositing additional coatings which may carry a fluorophore, or
by immobilizing a fluorophore on their surface. The layer-by-layer
technique (LbL) has turned out to be quite viable200 but the
stability may be an issue if the NPs are placed in complex samples
such as serum. The LbL technique consists in the deposition of
single layers of (polymer) molecules of alternating polarity or
charge and works best with alternatively charged ionic materials.
Methods for the functionalization of inorganic NPs for
bioimaging applications are rather diverse because conjugation
of NPs to specific biomolecules enables targeted imaging, can
reduce overall toxicity, and improve brightness. In general,
such NPs are modified in two steps, the first being surface
activation, the second being conjugation.201 The latter knows
numerous methods depending on the kind of species to be
immobilized. These range from polymers such as poly(ethylene
glycol) to proteins, fluorophores, oligomers or other particles.
Both physical adsorption and covalent binding have their
merits and are widely used. Quality criteria of the final product
include colloidal stability in water, biocompatibility, cell
permeability, and a brightness that enables even minute quan-
tities of NPs to be discerned from an often strongly fluorescent
background.202 Methods for the functionalization of the surface
of metal complex-derived NPs for use in molecular imaging have
been reviewed.203 One of the most versatile methods consists
in the biomimetic modification of the surface of NPs by phos-
pholipids as described in a milestone paper by the Selvin
group.204 The approach involves coating the surface of NPs with
a monolayer of phospholipids containing diﬀerent functional
terminal groups that can govern polarity and can render the
particles water soluble, for example, or conjugatable to bio-
molecules. These particles have a range of applications in
fields such as imaging and quantitative bioanalysis. Specifically,
dispersible and functionalized NPs were described for selective
imaging of live cancer cells. Also see a related recent article where
zwitterionic phospholipid coatings are employed.205
Many fluorescent NPs are simply coated with a shell of silica.
This introduces a negative charge on the surface and – more
importantly – protects the core from external quenchers. In
addition, the silica coating can also be made fluorescent with a
second dye and be further (bio)functionalized. Fig. 8 shows a
schematic of a typical process. Methods for coating NPs with
silica are well established and well reproducible. Biomedical
applications of organically modified bioconjugated silica NPs
have been reviewed.206
When deployed in vivo, NPs are typically protected from the
immune system by coating them with poly(ethylene glycol)
(PEG). A wide variety of strategies are known208 to coat and
characterize NPs with PEG. The core materials diﬀer strongly in
terms of size, shape, density, loading level, molecular weight,
charge and method for purification. However, other hydrogels
have been used that work as well. Jin et al.209 have coated
upconversion nanocrystals of the type NaYF4:Yb,Er with
poly(vinyl pyrrolidone, and then a ligand exchange reaction
was performed with polyethylenimine (PEI) and poly(acrylic
acid). The coated UCNPs can be dispersed in aqueous medium.
The positively charged PEI-coated particles are readily taken up
by cells (in comparison to their neutral or negatively charged
counterparts). The long-term in vivo biodistribution of poly-
acrylic acid-coated upconversion nanophosphors was imaged
and their toxicity is low.210 Others have coated UCNPs with the
hydrogel poly[(N-isopropylacrylamide)-co-(methacrylic acid)].211
Gelatine, another kind of hydrogel, was used to coat CdTe/CdSe
Q-dots to make them hydrophilic, more biocompatible and, thus,
suitable for bioimaging.212 The cell permeability of particles is
strongly improved if their surface is coated with poly-L-lysine.213
UCNPs are hydrophobic if prepared by the most common
method. In order to make them water-soluble, Liras et al.214
have capped the surface of UCNPs with a polymer by replacing
the original oleate ligand by multidentate thiolate grafting. The
side chains of the coating extend into the solution and render
the UCNPs water-dispersible. The resulting nanohybrids exhibit
an emission brighter by a factor of 10 in organic solvent and by a
factor of 2 even in water, and their fluorescence is highly
thermoresponsive. A review is available on the functionalization
of inorganic NPs including metal (Au, Ag), metal oxide (Fe3O4),
and semiconductor nanocrystals (e.g. quantum dots and magnetic
quantum dots) for bioimaging applications.215 Muhr et al.150 have
Fig. 8 Schematic of the common method for coating oleate-capped upconversion nanoparticles (UCNPs) with a shell of silica, and their subsequent
internalization into cells. From ref. 207 with permission.
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summarized methods for converting hydrophobic UCNPs (as
obtained by standard synthetic methods for making particles with
low dispersity) to water soluble hydrophilic UCNPs which is almost
mandatory if suchparticles are to beused inbioimaging. The state of
the art in the use of upconversion nanophosphors for small-animal
imaging,216 and ofmethods formodification and characterization of
UCNPs for use in bioanalytical methods217 have been reviewed.
The delivery of luminescent europium-coated NPs into
platelets can be controlled via the local pH values and can
occur within a few min.218 Gold NPs were coated with a lumi-
nescent Eu(III) complex (EuL) and the pHLIP peptide to give
particles of the type pHLIP/EuL@AuNPs. The 13 nm diameter
gold NPs act as a scaﬀold for the attachment of both the
luminescent probe and the peptide to target delivery. The NPs
enter the platelets under low pH conditions only, typically at pH
6.5, but not at pH 7.4, and this is mediated by pHLIP translocation
across the membrane. Luminescence microscopy images clearly
show the red luminescence of the europium probe.
If NPs are to be used for purposes of targeting (see Section
5.2), it is mandatory to modify the surface of the NP such that it
can recognize its target. It is known, for example, that the coating
of a surface with triphenylphosphonium groups (using reagents
such as MitoPt) will cause the particle to accumulate in the
proximity of mitochondria.219 This was exploited to visualize
oxygen tension at various sites on the microscale.220 Depending
on the kind of surface (silica, polylysine, or triphenylphospho-
nium groups), the polystyrene nanosensors are located in the
extracellular or intracellular space, or near mitochondria. A good
example for the architecture of a NP that can target cancer cells is
provided by the work of Cho et al.221 who have made rhodamine-
dyed NPs (B35 nm i.d.) highly biocompatible by coating the
surface with phosphocholine and lectin as shown in Fig. 9. Such
particles have a high aﬃnity for sialic acid as overexpressed on
the surface of tumor cells.
5. Specific examples on the use of
nanoparticles
5.1. Plain fluorescence imaging
In this case, the particles are simply added to the cell culture,
tissue, or vascular system to be imaged, usually by, but not
limited to microscopy. The only purpose of the particles is to
render cells fluorescent, and therefore they are expected to
display a large brightness, to be detectable in even deep regions
of tissue or in blood, not to be toxic, and not to respond to their
microenvironment (such as its local pH). NPs that work in the
optical window of biomatter, i.e. in the 600 to 900 nm range, are
strongly preferred, while probes with UV excitation suﬀer from
inner filter eﬀects on both the excitation and emission, and
from strong UV, blue and green background fluorescence of
most biomatter. Water-dispersible and fluorescent organic NPs
that are made more biocompatible by PEGylation and exploiting
the phenomenon of aggregation induced emission enhancement
have found particular interest in the past few years with respect to
cell imaging applications.222 Quite a number of articles have been
published in recent years on the use of NPs for plain imaging,
and a selection is presented in Table S1 in the ESI.†
5.2. Targeted bioimaging
If specific chemical groups or domains are to be detected, a
molecular probe (indicator), a labeling reagent (so to visualize
functional groups such as thiols), or a domain-recognizing
probe (that can target mitochondria or the glycolipids in
Alzheimer-associated tissue, for example) is being added. If
the species to be targeted is an intracellular protein, Q-dots
have been almost exclusively used in the past,223 but UCNPs
and C-dots are on the rise. Such methods are compromised,
however, by nonspecific binding, diﬃculty of intracellular deli-
very, or endosomal trapping of the NPs. Targeted bioimaging
Fig. 9 Architecture of a nanoparticle capable of targeting cancer cells. The surface is rendered biocompatible and negatively charged by coating it with
phosphocholine groups. Immobilization of lectin via biotin–streptavidin interaction results in particles that have extremely high affinity for sialic acid that
is overexpressed on the surface of cancer cells. The images show, from left to right, a TEM and fluorescence images of non-cancerous and cancerous
cells. From ref. 221 with permission (2014) of the Am. Chem. Soc.
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includes classical (not particle-based) methods of intracellular
immunostaining and in situ hybridization. Biju224 has reviewed
methods for chemicalmodifications and bioconjugate reactions
of nanomaterials such as silica NPs, gold NPs, gold quantum
clusters, semiconductor Q-dots, carbon nanotubes, fullerene
and graphene for use in (targeted) sensing and imaging.
Internalization is facilitated by modifying the surface with
poly(ethylene glycol) (PEG) and/or coating with a cell penetrating
peptide (which also avoids endosomal sequestration) and, finally,
with a receptor. The art of delivering bioconjugated quantum
dots to their targets and their uses for nonspecific extracellular
and intracellular imaging have been reviewed.225 Biocompatibility
and internalization are critical issues, and particles usually are
coated with PEG to impart or improve biocompatibility during
functional live-cell imaging. It was shown more recently that
sulfobetaine zwitterionic organic species on quantum dots serve
the same purpose.226 Specifically, bidentate zwitterionic dihydro-
lipoic acid–sulfobetaine ligands represent a favorable alternative to
PEG-coated NPs since they combine small size, low nonspecific
adsorption, and stability over time and a wide range of pH values
and salinity. In addition to using antibody-modified NPs, nano-
materials functionalized with DNA aptamers have been applied to
targeted imaging of specific sites inside cells.227
Tumor cells are best recognized by targeting their folate
receptor. It was targeted with an aggregation-enhanced fluores-
cent silica nanoprobe and used for both one-photon and two-
photon excited bioimaging.228 The two-photon technique can
overcome the limitations caused by fluorescence quenching
due to high chromophore loading and provided 3D cellular-
level resolution imaging of up to 350 mm deep in a HeLa tumor.
Hyaluronated fullerene with its strong NIR fluorescence also
allows for high-resolution fluorescence imaging of tumor sites
in vivo.229 Dually targeting upconversion nanocrystals were
obtained230 by attaching 3-aminophenylboronic acid and
hyaluronated fullerene to them. The two ligands warrant specific
targeting of cancer cells. In vivo single-cell pharmacokinetic
imaging of PARP-1 inhibitors and model drug behavior was
demonstrated231 under varying conditions. Cancer cells were
visualized through expression of H2B-apple (580 nm; red) and
TAMs were visualized by blue and fluorescent NPs internalized
into endosomes. The method is said to allow for gaining a better
insight into drug action in vivo.
Work on the use of DNA aptamer modified nanomaterials
for analysis of intracellular components and metabolites (also
including aspects of imaging) has been reviewed.232 A most
useful method for targeted imaging mRNA has been presented
by the Mirkin group.233 Their term ‘‘multiplexed nanoflare’’
stands for a NP agent capable of simultaneously detecting two
distinct mRNA targets inside a living cell. These probes are
spherical and consist of polynucleotides conjugated to gold NPs
as shown in Fig. 10. The oligomers are densely packed and
highly oriented, many of which are hybridized to a reporter
with a distinct fluorophore label and each complementary to its
corresponding mRNA target. If multiplexed nanoflares are
exposed to their targets, they provide a sequence specific signal
in both extra- and intracellular environments. One of the
targets can be used as an internal control, improving detection
by accounting for cell-to-cell variations in NP uptake and
background. Compared to single-component nanoflares, these
structures allow for a precise determination of relative levels of
mRNA in individual cells, but also have applications in cell
sorting. In yet another new scheme for targeting, bioorthogonal
(non-natural) chemistry was used to amplify NP binding and to
enhance the sensitivity of cell detection. Antibodies against
biomarkers were modified and used as scaﬀolds to couple NPs
to live cells.234 The group of Han235 has reviewed the use of
upconversion NPs as tools for multiscale targeted bioimaging.
Other examples are given in Table S2 in the ESI.†
5.3. Imaging of chemical species
There is substantial interest in visualizing chemical parameters
such as pH values or chemical species such as glucose,
calcium(II) or oxygen in the living and metabolizing cell, if
not in tumor cells or in cells exposed to candidate drugs.
Nanosensors have the unique feature of not being aﬀected by
intracellular species that often bind to molecular probes and
thereby may change their binding constants or act as quenchers.
The use of fluorescent NPs for intracellular sensing has been
reviewed by the Hall group.236
5.3.1. Imaging of pH values. Sensing of pH is by far the
most attractive option of fluorescence imaging because no other
method enables pH to be imaged andmonitored over time on the
nanoscale. Fig. 11 shows, exemplarily, an image of the distri-
bution of local pH values of a wound as imaged via the RGB
technique (see above) using sensor particles in a sprayable film.
Two kinds of polystyrene particles (one being pH-responsive
because of a fluorescent pH probe immobilized on its surface,
the other containing an inert reference fluorophore) were
applied.237 A smart approach was presented where photon
upconversion of respective NPs was applied to sensitize fluor-
escent nanoprobes for sensing and imaging of pH.238 In
another approach,239 a block copolymer labeled with dyes not
(!) sensitive to pH and with emission wavelengths from 500 to
820 nm was used to establish a panel of multicolored NPs with
Fig. 10 Schematic representation of target detection of mRNA by multi-
plexed nanoflares. The multiplexed nanoflares bind diﬀerent target nucleic
acids (shown in red and green), displacing the corresponding flare. Once
the flare is released, the fluorophore is no longer quenched by the gold
surface, and an increase in fluorescence can be measured. Using two
diﬀerent fluorophores, the ratio of each target can be determined in cells.
From ref. 233 with permission (2014) by the Am. Chem. Soc.
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diﬀerent pH transitions. The primary driving force of fluores-
cence activation between the unimer state and the micellar state
is pH-inducedmicellization. Each kind of NP displays a sharp pH
response (on/oﬀ within o0.25 pH units), with pH transition
points at pH 5.2, 6.4, 6.9, and 7.2. Incubation of a mixture of
multicolored NPs with human H2009 lung cancer cells demon-
strated their sequential activation inside endocytic compart-
ments. Table S3 in the ESI† gives an overview of the variety of
nanomaterials that have been employed to image pH values
inside various kinds of living cells, in tissue and on surfaces.
5.3.2. Imaging of oxygen. Aside from pH, there are species
that are essential for understanding the function of cells, in
(tumor) diagnosis, and in cellular testing including high-
throughput screening. Among these, oxygen is of particular
significance, and optical methods based on the use of NPs are
widely used.240 Wang et al.241 have applied the red-green-blue
techniques available with digital cameras to measure the distri-
bution of oxygen in normal rat kidney cells. Fig. 12 shows a
respective image. Nanosensors were made from polystyrene
containing two luminophores matching the red and the green
channels of digital color cameras. The red emission of the
oxygen probe is quenched by oxygen, while the blue-green
emitting reference fluorophore yields a constant signal.
Selected other nanomaterials for use in fluorescent imaging
of oxygen are summarized in Table S4 in the ESI.†
5.3.3. Imaging of other (bio)chemical species. Other
important classes of species include metal ions (from alkali
to heavy metal) and organic species such as glucose. It shall be
noted here, however, that several of the probes reported in the
literature (sometimes also referred to as ‘‘sensors’’) do not
respond in a reversible way so that they only can be used for
acquiring a single moment picture of a cell, but not to monitor
the ups and – in particular – the ‘‘downs’’ in the concentration
of a species over time. Such probes should not be termed a
‘‘sensor’’ and are not included here. Table S5 in the ESI† gives
examples of nanomaterials for use in imaging of cations such
as Mg(II) and Ca(II), of anions such as chloride, phosphate and
cyanide, of thiols, ROS and NO, and of metabolites such as
glucose.
5.4. Imaging of temperature
Conventional methods for measurement of temperature (T)
cannot be applied to cells and other nanostructures. In fact,
the use of molecular or NP-based optical probes is the only way
to intracellularly sense T. A review on this topic has appeared.37
One may diﬀerentiate between two kinds of nanomaterials that
can be used to sense T over time. The first makes use of one
or two fluorophores of which at least one displays a highly
T-dependent luminescence. If a single probe is used, the
determination of lifetime is the (referenced) method of choice.
If two fluorophores are used, one acts as the probe while the
other serves as a reference or as a partner in a FRET system. An
Eu(III) chelate probe in a silica matrix was claimed to possess
luminescence that strongly depends on T in the physiological
range.242 The second type is based on the use of fluorescent NPs
displaying intrinsic fluorescence, examples being Q-dots,243
C-dots,244 or upconverting nanocrystals which have the addi-
tional advantage of displaying two emission bands of diﬀerent
sensitivity to T.245 The group of Uchiyama246 was the first to
report on nanomaterial-based intracellular sensing of tempera-
ture by using a fluorescent polymeric thermometer and fluores-
cence lifetime imaging microscopy. The spatial and temperature
resolutions were at the diﬀraction limited level (200 nm) and
0.18–0.58 1C. The intracellular temperature distribution indicated
that the nucleus and centrosome of a COS7 cell showed a
significantly higher temperature than the cytoplasm and that
the temperature gap between the nucleus and the cytoplasm
differed depending on the cell cycle.
It appears that NPs prepared from a poly(methyl methacry-
late)-co-1,2-bis(trimethoxysilyl)decane composite and containing
a red-luminescent europium(III) complex display the best sensi-
tivity to T at present.247 The NPs also contain a green-emitting
and virtually T-independent reference dye. The ratio of the green
and a red fluorescence under single-wavelength excitation is
highly dependent on T in the 25–45 1C range, with a sensitivity
of 4.0% per 1C. Given their small size (20–30 nm) and
biocompatibility (due to the presence of an outer layer of silica),
such NPs are likely to be useful nanoprobes for imaging of T
inside cells. Silica NPs doped with the T-probe Ru(bpy) were
also used248 to image intracellular T but have a smaller sensi-
tivity (expressed as the signal change DS per 1C). An interesting
Fig. 11 Pseudocolor images of pH values on an inflammated wound.
Bluish colors indicate fairly intact skin (with pH values between 5 and 6),
whilst green and red colors represent areas of sustained inflammation and
partial granulation. From ref. 237.
Fig. 12 RGB image (A) and ratiometric image (B) of the distribution of
oxygen in NRK cells using nanosensors for oxygen. The brightness of the
red luminescence (resulting from the probe for oxygen) and the green
luminescence (of the reference dye) are stored in 2 diﬀerent memories
and can be used to calculate the ratio for each single pixel. It can be
plotted in pseudo-colours (right) to reflect the local oxygen partial
pressure. From ref. 241. r Royal Soc. Chem.
Chem Soc Rev Review Article
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
6 
Ja
nu
ar
y 
20
15
. D
ow
nl
oa
de
d 
on
 2
3/
02
/2
01
6 
15
:3
2:
51
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
4760 | Chem. Soc. Rev., 2015, 44, 4743--4768 This journal is©The Royal Society of Chemistry 2015
method, albeit not applied to imaging, is exploiting the T-sensitive
fluorescence of NaYF4:Er,Yb3 upconversion NPs, where the inten-
sity ratio of the two green bands of the Er(III) dopant changes with
temperature.249 It was applied to measure T inside HeLa cells.
Representative other nanomaterials and their features in terms of
optical sensing of T are complied in Table S6 in the ESI.†
6. Multimodal imaging, and imaging
combined with drug and gene delivery,
or with (photodynamic) therapy
One very exciting trend at present involves a combination of
fluorescent imaging with other methods of imaging, mainly
magnetic resonance imaging (MRI), plasmonic imaging, and
positron emission tomography (PET) imaging. This is referred
to as bimodal or multimodal imaging. Another one involves the
combination of fluorescent imaging with drug or gene delivery
but these rely on the release of a diagnostically active species.
A third (and closely related one) involves fluorescent imaging
combined with photodynamic therapy (PDT) or photothermal
therapy (PTD) where agents may be, or may not be, released
from the NPs. These methods shall be discussed in the follow-
ing sections, again mainly from a nanomaterials point of view.
6.1. Multimodal imaging
Fluorescent NPs, magnetic NPs, and plasmonic NPs are the
three most common nanoparticles when looking at the particle
functionality. Their use in multimodal imaging has been briefly
reviewed.250 Depending on the kind of multimodal imaging, a
second species is required to be present in the NP in addition to
a fluorescent probe that will give a signal in MRI or PET. This
section gives examples in addition to those already described
earlier in this review (search for bimodal or multimodal). A
typical example251 is provided by the use of a nanocomposite
consisting of magnetic iron oxide NPs and single-walled CNTs.
These heterostructured complexes were utilized as bioimaging
agents after encapsulation with oligonucleotides with the
sequence d(GT)15 and enrichment using a 0.5 Tesla magnetic
array. The resulting nanotube complexes show distinct NIR
fluorescence, Raman scattering, and visible/NIR absorbance.
Macrophage cells that engulf the DNA-wrapped complexes were
imaged using MRI and NIR mapping.
Dendrimer based bimodal imaging with longwave emitting
fluorophores (these are preferred for the reasons indicated
before) was shown for a fluorinated dendron conjugated to a
cyanine dye for bimodal MRI and NIR fluorescence imaging.252
Bimodal upconversion fluorescence and X-ray imaging was also
accomplished253 by using hexagonal phase NaLuF4:Gd/Yb/Er
nanorods, and blood vessels of lung were visualized with the
aim to improve the diagnosis of lung and pulmonary vascular
diseases. It is advised to read the critical comment by van
Veggel et al.254 on the use of lanthanide-doped NPs for fluores-
cence and MRI. Dual mode nanoprobes (without obvious cyto-
toxicity) for targeted bimodal fluorescent imaging and MRI of
MCF-7 breast cancer cells were obtained255 by co-encapsulation
of an NIR-emissive conjugated polymer and lipid-coated iron
oxides (IOs) in a hydrophilic poly(lactic-co-glycolic-acid)–poly-
(ethylene glycol) composite and coating the 180 nm particles
with folic acid.
An important recent finding is the eﬀect of the size and the
phase on the multimodality of co-encapsulated magnetic photon-
upconverting polymeric NPs for use in bimodal (fluorescent/
magnetic resonance) imaging.256 In another sophisticated
approach, the large potential of multimodal functionality was
impressively demonstrated257 by showing that NPs of the layer
architecture UCNP@mSiO2–Ln(dbm)4 (where mSiO2 stands for
mesoporous silica, Ln for any trivalent ion out of Eu, Sm, Er, Nd,
Yb; and dbm stands for the organic ligand complexing the Ln ion).
Both downconversion and upconversion luminescence are found,
and this results inmulticolor emission (covering the spectral region
from 450 nm to 1700 nm) under visible-light excitation and 980 nm
excitation, respectively. The mesoporous materials were applied to
in vitro imaging based on Eu(III) luminescence (under 405 nm
excitation), and to small animal imaging based on Tm(III) lumines-
cence (under 980 nm excitation). In addition, the Gd(III) dopant
causes T1 signal enhancement and thus makes them potential
contrast agents for MRI. This is schematically shown in Fig. 13.
Other multifunctional nanocomposites include those for dual
luminescence imaging, especially those showing both upconver-
sion and downconversion luminescence.258
Bimodal surface enhanced Raman spectroscopy along with
3D fluorescence imaging based on the use of NPs is rather new.
In the first approach of that kind,259 a rhodamine dye was
conjugated to gold NPs which then were applied to live
endothelial cells and revealed inhomogeneous distribution in
the cytoplasm. Table S7 in the ESI† summarizes other repre-
sentative examples of NPs for use in multimodal imaging.
Fig. 13 Schematic of the preparation and structure of multifunctional meso-
porous NPs containing both upconversion and magnetic nanophosphors
(with an architecture of the type NaYF4:Yb,Tm@NaGdF4) and covered with a
conventional luminescent lanthanide complex (Ln-dbm) for use in upconver-
sion and downconversion luminescence imaging and as T1-weighed MRI
contrast agents. From ref. 257r RSC.
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6.2. Imaging combined with drug delivery, gene delivery or
chemotherapy
Theranostics with the cancer drug cis-platin has attracted much
interest. Nanoparticles consisting of an upconversion fluores-
cent core and a porous silica shell were applied, for example, to
deliver cis-platin to tumors. Such NPs may even be used in
synergistic chemo- and radiotherapy by radiosensitization
of the cis-platin in the shell, and in magnetic/luminescent
bimodal imaging.260 The design of multifunctional upconversion
NPs coated with a polymer nanocomposites for use in the delivery
of cis-platin and in biomedical imaging was also described.261 In a
series of articles, the groups of Qu and Ren have impressively
shown how fluorescence nanoparticles prepared from various
materials can be applied to simultaneous imaging and delivery
of genes and drugs. In one example, polycation-functionalized
and water-soluble gold nanoclusters were constructed that act as a
platform for simultaneous gene delivery and cell imaging.262 In
another, lanthanide-modified hollow mesoporous nanoparticles
were also shown to serve this purpose.263 Dextranes, in cross-
linked form, can also be used to prepare NPs for use in in vitro
drug release by loading dextran–chitosan NPs with the drug
curcumin.264 C-dots were shown to be useful nanocarriers for
gene delivery and bioimaging. They were prepared by pyrolysis of
glycerol in the presence of polyethylenimine which imparts better
brightness.265 Advances in lanthanide ion-based upconversion
nanomaterials for drug delivery have been reviewed recently.266
Further examples are given in Table S8 in the ESI.†
In impressive work on multimodally functional NPs, chemo-
, radio- and photodynamic therapy and simultaneous MRI/UCL
imaging have been demonstrated for a single kind of NP.267
This represents an exciting leap forward. By integrating upcon-
version NPs and mesoporous silica into a single platform,
diagnostic/therapeutic functions were combined to provide a
more advanced way for the eﬃcient theranostics of cancer.
Specifically, multifunctional Gd(III)-UCNPs with a mesoporous
silica shell were constructed for the co-delivery of a radio-/
photo-sensitizer hematoporphyrin (HP) and the radiosensitizer
and chemodrug docetaxel. Upon NIR excitation and X-ray irra-
diation, a tumor was eliminated by the synergistic chemo-/
radio-/photodynamic tri-modal therapy under the assistance of
simultaneous magnetic and luminescent bimodal imaging. In
other exciting work,268 upconversion NPs of the type BaGdF5;
10 nm in size were shown (a) to act as carriers for the drug
doxorubicin; (b) to act as multimodal probes for simultaneous
imaging (optical/magnetic/X-ray/CT) and drug release which
can be triggered by low pH. This exciting approach was applied
to kill HeLa cells.
6.3. Imaging combined with photodynamic or photothermal
therapy
The heating eﬀect exerted by cw-laser light as used for photo-
excitation of upconversion NPs is the result of the absorbance
of light by such NPs and by their aqueous microenvironment
because water has a weak overtone absorption at above 850 nm.
This was exploited in a bimodal scheme for UCNP-based
imaging and photothermal therapy (PDT).269 Similarly, in vivo
optical imaging and PDT of tumors were accomplished with
upconversion NPs with a NaYF4:Yb,Er core and a NaGdF4 shell
combined with the photosensitizer chlorin e6. Tumors were
observed both in the luminescence images and via MRI.
In vivo PDT was simultaneously triggered by irradiation with
980 nm light.270 Related studies were performed where PDT is
based on the multicolor emission capability of upconversion NPs
at a single excitation wavelength that can simultaneously activate
two photosensitizers. Mice were photodynamically treated by
direct injection of the NPs into melanoma tumors or by intrave-
nous injection of NPs conjugated to a tumor-targeting agent.271
Dextran based NPs dyed with Indocyanine Green can be
used for NIR imaging and PDT in vitro.272 The dye is retained by
electrostatic interactions, and the NPs are well biocompatible
and readily internalized because the dextran is block copoly-
merized with PEG. Even triple-functional core–shell structured
NPs were reported more recently.273 The NPs were covalently
grafted with a photosensitizer for luminescent, magnetic reso-
nance imaging and PDT in vivo. Representative examples of NPs
that have been used for these purposes are summarized in
Table S9 in the ESI.†
7. Conclusions and outlook
The state of the art in fluorescent imaging is impressive. This
is due to the progress made in materials science and in
spectroscopy and microscopy. The number of nanomaterials,
mainly nanoparticles, for use in fluorescent imaging is entan-
gling, however, and a newcomer may find it diﬃcult to make
the appropriate selection. Depending on the kind of applica-
tion, diﬀerent kinds of criteria may apply when selecting
particles. Nanoparticles always are preferred in intracellular
studies, and often preferred (over microparticles) in extra-
cellular studies. Table 2 gives an overview of figures of merit
for the classes of NPs that are more widely used. The following
criteria apply when selecting nanoparticles for use in fluores-
cence imaging:
(a) Plain imaging requires bright particles that are non-toxic
and – if this is needed – well cell permeable. Candidate
materials include upconversion nanocrystals, C-dots, Q-dots
(if properly coated), dyed particles consisting of (mesoporous)
silica or polystyrene, and semiconductor P-dots.
(b) Targeted (cellular) imaging requires bright particles that
are not (cell-)toxic and, if needed, cell permeable. As their
surface has to be coated with a ligand binding to the target
(the receptor), their surface has to be modified which is easy in
the case of silica particles and silica-coated upconversion
materials, also with C-dots and particles made from PAA, but
less so with P-dots and with most hydrophobic organic
particles.
(c) NPs for use in chemical sensing are supposed, first of all,
to be selective and, ideally, hardly aﬀected by temperature.
Biocompatibility is needed in the case of imaging biosystems,
of course. Sensors working in the optical (spectral) window of
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biomatter (i.e. between 600 and 900 nm) are preferred. Such
sensors should also be calibratable in vivo.
(d) NPs for use in imaging of temperature (T) are, first of
all, expected to be completely inert except for the T-dependence of
their luminescence. Depending on the application, bio-
compatibility and cell permeability may be required. They are
supposed to respond to T with a large signal change which results
in a good resolution. In medical and bioapplications, the resolu-
tion is supposed to be better than 0.2 1C in the 20–55 1C range.
Other nanosensors are supposed to work over a wide range of Ts,
and this will not require such a good resolution.
(e) NPs for use in multimodal imaging require nanomaterials
of high sophistication. Such NPs are expected to display bright
fluorescence and, in parallel, to be applicable to a second kind of
imaging, MRI for example. Hence, additional functional materials
have to be incorporated into the core or the shell of the NPs
however without compromising other properties including size
and cell viability.
(f) NPs for use in optical imaging along with (cancer) therapy
also require nanomaterials of high sophistication. Particles are
preferably covered with porous shells that can be loaded with a
drug, a gene or a photodynamic or a photothermal agent. Drugs
and genes can be released once the NPs have arrived at the site
of action. Controlled release can be induced by light or by
changes in the local pH value, for example.
Given the number of conceivable applications of nano-
particles in the very large medical field (cancer diagnosis and
therapy mainly), in bioanalysis, biology, the military, security
(from documents to banknotes) and in various kinds of technical
nanosystems, it is diﬃcult to make general recommendation but
it is hoped that readers will find this review to be of help when
making decisions as to what material to be chosen.
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